Tech Company Inital Public Offerings
Trevena IPO
Trevena was acquired by . Shares were listed on 1/31/2014.
Transaction Overview
Company Name
Announced On
1/31/2014
Transaction Type
IPO
Amount
$65,100,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1018 West 8th Ave. A
King of Prussia, PA 19406
USA
King of Prussia, PA 19406
USA
Phone
Website
Email Address
Overview
Trevena (NASDAQ: TRVN) is a drug discovery company focused on developing pharmaceutical products targeting G-protein coupled receptors (GPCRs).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Maxine Gowen
Chief Financial Officer
Roberto Cuca
Chief Scientific Officer
Michael Lark
VP - Bus. Development
David Soergel
VP - General Counsel
John Limongelli
Browse more venture capital transactions:
Prev: 1/31/2014: ScootNetworks venture capital transaction
Next: 1/31/2014: Stoke venture capital transaction
Share this article
About Database of VC Transactions
We document every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs